Renal Cell Carcinoma
November 22, 2023
Adjuvant Everolimus Improves Recurrence-Free Survival in Very High–Risk Renal Cell Carcinoma
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
March 16, 2023
Extended Follow-up Supports First-Line Use of Nivolumab Plus Cabozantinib in Advanced Renal Cell Carcinoma
The ASCO Post
July 14, 2023
Novel Radiotracer May Accurately Detect and Differentiate Renal Cell Carcinomas
The ASCO Post
Advertisement
Recommendations
Advertisement